Literature DB >> 19564335

Hypoxia-induced expression of carbonic anhydrase 9 is dependent on the unfolded protein response.

Twan van den Beucken1, Marianne Koritzinsky, Hanneke Niessen, Ludwig Dubois, Kim Savelkouls, Hilda Mujcic, Barry Jutten, Juraj Kopacek, Sylvia Pastorekova, Albert J van der Kogel, Philippe Lambin, Willem Voncken, Kasper M A Rouschop, Bradly G Wouters.   

Abstract

Adaptation to tumor hypoxia is mediated in large part by changes in protein expression. These are driven by multiple pathways, including activation of the hypoxia inducible factor-1 (HIF-1) transcription factor and the PKR-like endoplasmic reticulum kinase PERK, a component of the unfolded protein response. Through gene expression profiling we discovered that induction of the HIF-1 target gene CA9 was defective in mouse embryo fibroblasts derived from mice harboring an eIF2alpha S51A knock-in mutation. This finding was confirmed in two isogenic human cell lines with an engineered defect in eIF2alpha phosphorylation. We show that impaired CA9 expression was not due to changes in HIF activity or CA9 mRNA stability. Using chromatin immunoprecipitation we show that the eIF2alpha-dependent translationally regulated gene ATF4 binds directly to the CA9 promoter and is associated with loss of the transcriptional repressive histone 3 lysine 27 tri-methylation mark. Loss or overexpression of ATF4 confirmed its role in CA9 induction during hypoxia. Our data indicate that expression of CA9 is regulated through both the HIF-1 and unfolded protein response hypoxia response pathways in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19564335      PMCID: PMC2782014          DOI: 10.1074/jbc.M109.006510

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Translational control is required for the unfolded protein response and in vivo glucose homeostasis.

Authors:  D Scheuner; B Song; E McEwen; C Liu; R Laybutt; P Gillespie; T Saunders; S Bonner-Weir; R J Kaufman
Journal:  Mol Cell       Date:  2001-06       Impact factor: 17.970

2.  Transcriptional regulation of the MN/CA 9 gene coding for the tumor-associated carbonic anhydrase IX. Identification and characterization of a proximal silencer element.

Authors:  S Kaluz; M Kaluzová; R Opavský; S Pastoreková; A Gibadulinová; F Dequiedt; R Kettmann; J Pastorek
Journal:  J Biol Chem       Date:  1999-11-12       Impact factor: 5.157

3.  Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density.

Authors:  N J Beasley; C C Wykoff; P H Watson; R Leek; H Turley; K Gatter; J Pastorek; G J Cox; P Ratcliffe; A L Harris
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

4.  Hypoxia-inducible expression of tumor-associated carbonic anhydrases.

Authors:  C C Wykoff; N J Beasley; P H Watson; K J Turner; J Pastorek; A Sibtain; G D Wilson; H Turley; K L Talks; P H Maxwell; C W Pugh; P J Ratcliffe; A L Harris
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

5.  Regulated translation initiation controls stress-induced gene expression in mammalian cells.

Authors:  H P Harding; I Novoa; Y Zhang; H Zeng; R Wek; M Schapira; D Ron
Journal:  Mol Cell       Date:  2000-11       Impact factor: 17.970

6.  Quantitative analysis of varying profiles of hypoxia in relation to functional vessels in different human glioma xenograft lines.

Authors:  P F J W Rijken; J P W Peters; A J Van der Kogel
Journal:  Radiat Res       Date:  2002-06       Impact factor: 2.841

Review 7.  Biological consequences of tumor hypoxia.

Authors:  M Höckel; P Vaupel
Journal:  Semin Oncol       Date:  2001-04       Impact factor: 4.929

8.  Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha.

Authors:  Constantinos Koumenis; Christine Naczki; Marianne Koritzinsky; Sally Rastani; Alan Diehl; Nahum Sonenberg; Antonis Koromilas; Bradly G Wouters
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

9.  The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF.

Authors:  Sophie Beyer; Malene Maag Kristensen; Kim Steen Jensen; Jens Vilstrup Johansen; Peter Staller
Journal:  J Biol Chem       Date:  2008-11-04       Impact factor: 5.157

10.  Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3'-kinase.

Authors:  Stefan Kaluz; Milota Kaluzová; Adrian Chrastina; Peggy L Olive; Silvia Pastoreková; Jaromír Pastorek; Michael I Lerman; Eric J Stanbridge
Journal:  Cancer Res       Date:  2002-08-01       Impact factor: 12.701

View more
  29 in total

Review 1.  Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2.

Authors:  Nanduri R Prabhakar; Gregg L Semenza
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

Review 2.  Translational regulator eIF2α in tumor.

Authors:  Qiaoli Zheng; Jingjia Ye; Jiang Cao
Journal:  Tumour Biol       Date:  2014-03-09

Review 3.  Cell intrinsic and extrinsic activators of the unfolded protein response in cancer: Mechanisms and targets for therapy.

Authors:  Feven Tameire; Ioannis I Verginadis; Constantinos Koumenis
Journal:  Semin Cancer Biol       Date:  2015-04-25       Impact factor: 15.707

Review 4.  Targeting hypoxia in cancer therapy.

Authors:  William R Wilson; Michael P Hay
Journal:  Nat Rev Cancer       Date:  2011-06       Impact factor: 60.716

Review 5.  Epigenetic programming of hypoxic-ischemic encephalopathy in response to fetal hypoxia.

Authors:  Qingyi Ma; Lubo Zhang
Journal:  Prog Neurobiol       Date:  2014-11-11       Impact factor: 11.685

6.  Assessment of carbonic anhydrase IX expression and extracellular pH in B-cell lymphoma cell line models.

Authors:  Liu Qi Chen; Christine M Howison; Catherine Spier; Alison T Stopeck; Scott W Malm; Mark D Pagel; Amanda F Baker
Journal:  Leuk Lymphoma       Date:  2014-11-10

7.  PERK/eIF2α signaling protects therapy resistant hypoxic cells through induction of glutathione synthesis and protection against ROS.

Authors:  Kasper M Rouschop; Ludwig J Dubois; Tom G Keulers; Twan van den Beucken; Philippe Lambin; Johan Bussink; Albert J van der Kogel; Marianne Koritzinsky; Bradly G Wouters
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-07       Impact factor: 11.205

8.  Activation of HIF-1α does not increase intestinal tumorigenesis.

Authors:  Xiang Xue; Sadeesh K Ramakrishnan; Yatrik M Shah
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-29       Impact factor: 4.052

9.  Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype.

Authors:  K Ameri; R Luong; H Zhang; A A Powell; K D Montgomery; I Espinosa; D M Bouley; A L Harris; S S Jeffrey
Journal:  Br J Cancer       Date:  2010-01-05       Impact factor: 7.640

10.  HIGD1A Regulates Oxygen Consumption, ROS Production, and AMPK Activity during Glucose Deprivation to Modulate Cell Survival and Tumor Growth.

Authors:  Kurosh Ameri; Arman Jahangiri; Anthony M Rajah; Kathryn V Tormos; Ravi Nagarajan; Melike Pekmezci; Vien Nguyen; Matthew L Wheeler; Michael P Murphy; Timothy A Sanders; Stefanie S Jeffrey; Yerem Yeghiazarians; Paolo F Rinaudo; Joseph F Costello; Manish K Aghi; Emin Maltepe
Journal:  Cell Rep       Date:  2015-02-13       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.